Clinical Characteristics, Treatment, and Short-Term Outcome in Patients with Heart Failure and Cancer.
MetadataShow full item record
Piotrowski, J., Timler, M., Kozłowski, R., Stasiak, A., Stasiak, J., Bissinger, A., Timler, D., et al. (2021). Clinical Characteristics, Treatment, and Short-Term Outcome in Patients with Heart Failure and Cancer.. Clin Pract, 11 (4), 933-941. https://doi.org/10.3390/clinpract11040107
(1) Our study aimed to look at the clinical characteristics, treatment and short-term outcomes of patients hospitalized due to heart failure with coexisting cancer. (2) Methods: Seventy one cancer (Ca) patients and a randomly selected 70 patients without Ca, hospitalized due to heart failure exacerbation in the same time period constituted the study group (Ca patient group) and controls (non-Ca group), respectively. Data on clinical characteristics were collected retrospectively for both groups. (3) Results: Cancer patients presented with a less advanced NYHA class, had more frequent HFpEF, a higher peak troponin T level, and smaller left atrium size, as compared with controls. The in-hospital deaths of Ca patients were associated with: a higher New York Heart Association (NYHA) class, lower HgB level, worse renal function, higher K and AST levels, presence of diabetes mellitus, and HFpEF. By multivariate logistic regression analysis, impaired renal function was the only independent predictor of in-hospital death in Ca patients (OR-1.15; CI 1.05; 1.27); p = 0.017). The following covariates entered the regression: NYHA class, HgB, GFR, K+, AST, diabetes mellitus t.2, and HFpEF. (4) Conclusions: The clinical picture and the course of heart failure in patients with and without cancer are different.
cancer, heart failure, treatment, short-term outcome
External DOI: https://doi.org/10.3390/clinpract11040107
This record's URL: https://www.repository.cam.ac.uk/handle/1810/331807
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org